Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204309491> ?p ?o ?g. }
- W3204309491 endingPage "1087" @default.
- W3204309491 startingPage "1081" @default.
- W3204309491 abstract "Anxiety disorders are the most common mental disorders in adolescents. However, only 50% of pediatric patients with anxiety disorders respond to the first-line pharmacologic treatments-selective serotonin reuptake inhibitors (SSRIs). Thus, identifying the neurofunctional targets of SSRIs and finding pretreatment or early-treatment neurofunctional markers of SSRI treatment response in this population is clinically important. We acquired pretreatment and early-treatment (2 weeks into treatment) functional magnetic resonance imaging during a continuous processing task with emotional and neutral distractors in adolescents with generalized anxiety disorder (GAD, N = 36) randomized to 8 weeks of double-blind escitalopram or placebo. Generalized psychophysiological interaction analysis was conducted to examine the functional connectivity of the amygdala while patients viewed emotional pictures. Full-factorial analysis was used to investigate the treatment effect of escitalopram on amygdala connectivity. Correlation analyses were performed to explore whether pretreatment and early (week 2) treatment-related connectivity were associated with treatment response (improvement in anxiety) at week 8. Compared to placebo, escitalopram enhanced emotional processing speed and enhanced negative right amygdala-bilateral ventromedial prefrontal cortex (vmPFC) and positive left amygdala-right angular gyrus connectivity during emotion processing. Baseline amygdala-vmPFC connectivity and escitalopram-induced increased amygdala-angular gyrus connectivity at week 2 predicted the magnitude of subsequent improvement in anxiety symptoms. These findings suggest that amygdala connectivity to hubs of the default mode network represents a target of acute SSRI treatment. Furthermore, pretreatment and early-treatment amygdala connectivity could serve as biomarkers of SSRI treatment response in adolescents with GAD. The trial registration for the study is ClinicalTrials.gov Identifier: NCT02818751." @default.
- W3204309491 created "2021-10-11" @default.
- W3204309491 creator A5009278015 @default.
- W3204309491 creator A5010194987 @default.
- W3204309491 creator A5017607647 @default.
- W3204309491 creator A5021572435 @default.
- W3204309491 creator A5028706067 @default.
- W3204309491 creator A5030429211 @default.
- W3204309491 creator A5055637525 @default.
- W3204309491 creator A5057656830 @default.
- W3204309491 creator A5058853115 @default.
- W3204309491 creator A5076055846 @default.
- W3204309491 creator A5091162498 @default.
- W3204309491 date "2021-09-27" @default.
- W3204309491 modified "2023-10-15" @default.
- W3204309491 title "Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial" @default.
- W3204309491 cites W1817974734 @default.
- W3204309491 cites W1883796973 @default.
- W3204309491 cites W1969202421 @default.
- W3204309491 cites W1983183519 @default.
- W3204309491 cites W1985472839 @default.
- W3204309491 cites W2012675869 @default.
- W3204309491 cites W2020134481 @default.
- W3204309491 cites W2049511110 @default.
- W3204309491 cites W2051593922 @default.
- W3204309491 cites W2052478013 @default.
- W3204309491 cites W2060157627 @default.
- W3204309491 cites W2068673705 @default.
- W3204309491 cites W2074173036 @default.
- W3204309491 cites W2075019180 @default.
- W3204309491 cites W2089572795 @default.
- W3204309491 cites W2100358211 @default.
- W3204309491 cites W2101842006 @default.
- W3204309491 cites W2106890437 @default.
- W3204309491 cites W2123350238 @default.
- W3204309491 cites W2124526585 @default.
- W3204309491 cites W2126449881 @default.
- W3204309491 cites W2131873172 @default.
- W3204309491 cites W2132137022 @default.
- W3204309491 cites W2138219516 @default.
- W3204309491 cites W2163659555 @default.
- W3204309491 cites W2166275336 @default.
- W3204309491 cites W2168778334 @default.
- W3204309491 cites W2414922822 @default.
- W3204309491 cites W2514984695 @default.
- W3204309491 cites W2523729379 @default.
- W3204309491 cites W2553993334 @default.
- W3204309491 cites W2555107623 @default.
- W3204309491 cites W2569703207 @default.
- W3204309491 cites W2580637087 @default.
- W3204309491 cites W2606531459 @default.
- W3204309491 cites W2755732590 @default.
- W3204309491 cites W2766048977 @default.
- W3204309491 cites W2791558269 @default.
- W3204309491 cites W2808444231 @default.
- W3204309491 cites W2891546677 @default.
- W3204309491 cites W2912141202 @default.
- W3204309491 cites W2971724231 @default.
- W3204309491 cites W3001336471 @default.
- W3204309491 cites W3045550692 @default.
- W3204309491 cites W3046527398 @default.
- W3204309491 cites W3080184330 @default.
- W3204309491 cites W3126667232 @default.
- W3204309491 cites W4236592671 @default.
- W3204309491 cites W4247665917 @default.
- W3204309491 doi "https://doi.org/10.1038/s41386-021-01186-0" @default.
- W3204309491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34580419" @default.
- W3204309491 hasPublicationYear "2021" @default.
- W3204309491 type Work @default.
- W3204309491 sameAs 3204309491 @default.
- W3204309491 citedByCount "5" @default.
- W3204309491 countsByYear W32043094912022 @default.
- W3204309491 countsByYear W32043094912023 @default.
- W3204309491 crossrefType "journal-article" @default.
- W3204309491 hasAuthorship W3204309491A5009278015 @default.
- W3204309491 hasAuthorship W3204309491A5010194987 @default.
- W3204309491 hasAuthorship W3204309491A5017607647 @default.
- W3204309491 hasAuthorship W3204309491A5021572435 @default.
- W3204309491 hasAuthorship W3204309491A5028706067 @default.
- W3204309491 hasAuthorship W3204309491A5030429211 @default.
- W3204309491 hasAuthorship W3204309491A5055637525 @default.
- W3204309491 hasAuthorship W3204309491A5057656830 @default.
- W3204309491 hasAuthorship W3204309491A5058853115 @default.
- W3204309491 hasAuthorship W3204309491A5076055846 @default.
- W3204309491 hasAuthorship W3204309491A5091162498 @default.
- W3204309491 hasBestOaLocation W32043094911 @default.
- W3204309491 hasConcept C118552586 @default.
- W3204309491 hasConcept C142724271 @default.
- W3204309491 hasConcept C15744967 @default.
- W3204309491 hasConcept C169760540 @default.
- W3204309491 hasConcept C169900460 @default.
- W3204309491 hasConcept C204787440 @default.
- W3204309491 hasConcept C27081682 @default.
- W3204309491 hasConcept C2778627534 @default.
- W3204309491 hasConcept C2779144063 @default.
- W3204309491 hasConcept C2779177272 @default.
- W3204309491 hasConcept C2779583969 @default.
- W3204309491 hasConcept C2781195155 @default.